Sachetta’s Royalty Pharma RPRX Stock Holding History

Sachetta’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.11K	Buy	109 +12	+12%	+$625	﹤0.01%	598
2026 Q1	$4.65K	Hold	97	–	–	﹤0.01%	683
2025 Q4	$3.75K	Hold	97	–	–	﹤0.01%	625
2025 Q3	$3.42K	Hold	97	–	–	﹤0.01%	696
2025 Q2	$3.5K	Buy	97 +48	+98%	+$1.59K	﹤0.01%	674
2025 Q1	$1.53K	Hold	49	–	–	﹤0.01%	845
2024 Q4	$1.25K	Sell	49 -23	-32%	-$610	﹤0.01%	942
2024 Q3	$2.04K	Hold	72	–	–	﹤0.01%	870
2024 Q2	$2.06K	Buy	72 +29	+67%	+$804	﹤0.01%	819
2024 Q1	$1.21K	Hold	43	–	–	﹤0.01%	869
2023 Q4	$1.21K	Buy	+43	New	+$1.18K	﹤0.01%	869

Other funds holding RPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

FCG Investment Company Germantown, Tennessee $289M AUM